SRG announced the appointment of Andrew Turner to the role of Managing Director.
Turner joins SRG to execute the strategic and commercial leadership of the business, reporting in to Impellam’s STEM portfolio CEO Kelly Morton. Turner will drive SRG’s strategic vision and direct the development of new services and client offerings, while strengthening SRG’s people-centric business culture.
Commenting on the appointment, Kelly Morton, STEM Portfolio CEO at Impellam Group, said: “Andrew has an amazing and award-winning record of success. He understands what is needed to help our clients to build better businesses with the specialised talent SRG are experts in finding. I look forward to working with Andrew to establish and elevate our STEM recruitment and I’m confident in his ability to continue SRG’s mission in building tomorrow’s world through powerful partnerships”.
Andrew Turner, Managing Director SRG, said: “Having enjoyed a career with Impellam for a number of years, I am looking forward to beginning my journey with Kelly and SRG. SRG’s dedication to empowering individuals and STEM businesses to enhance the now and shape the future is not only inspiring, but crucial to match the ever-evolving needs of the STEM industries. I believe SRG’s established talent network and partnership model places us in a unique position to solve the issue of futureproofing talent pipelines in scientific businesses across the world.”
Turner joins SRG following an established career in strategic and commercial leadership for some of Impellam’s global brands, most recently in the Asia and Pacific Regions. As Executive Director for Medacs, Global Medics and Litmus Workforce Solutions, Turner oversaw a full-scale business transformation including significant expansion of sales and operational functions to standardise business practice and streamline cost bases.